📊 Evidence-Based Reference

philips intellivue tcg10

Philips Medizinsysteme Boeblingen Gmbh, Cardiac An

Summary: The Philips IntelliVue TCG10 is a clinician-facing device used for patient monitoring, particularly in cardiac care. It is FDA 510k cleared and supported by evidence from 10 studies, focusing on its efficacy and safety in clinical settings.

FDA Clearance Information

Pathway 510K
Decision Date September 30, 2011
Product Code LKD
Device Class Class 2
Evidence 419 studies

The Philips IntelliVue TCG10 was cleared through the FDA 510k pathway on September 30, 2011. It is manufactured by Philips Medizinsysteme Boeblingen Gmbh and classified as a Class 2 device.

What It Is

The Philips IntelliVue TCG10 is a patient monitoring device designed for use in clinical settings to monitor cardiac and other vital signs. It is intended to provide real-time data to clinicians for informed decision-making in patient care.

Clinical Applications

The device is commonly used in hospital settings, particularly in cardiac care units, to monitor patients for potential arrhythmias and other critical conditions. It aids in the continuous assessment of patient status, helping to prevent adverse events.

Evidence Summary

The available literature includes 10 studies, comprising various study types such as observational and usability studies, conducted between 2021 and 2025. These studies evaluate the device's performance, usability, and safety in clinical environments.

Reported Outcomes

Published studies report that the Philips IntelliVue TCG10 is effective in detecting cardiac arrhythmias and providing reliable patient monitoring data. Usability studies highlight its user-friendly interface, which is preferred by clinical staff.

Safety Profile

Reported complications include potential alarm fatigue due to high false alarm rates, as noted in studies comparing multiple monitoring systems. No significant adverse events specific to the Philips IntelliVue TCG10 were highlighted in the reviewed literature.

Evidence Limitations

The evidence is limited by the small number of studies directly evaluating the Philips IntelliVue TCG10. Further research is needed to explore long-term outcomes and compare its performance with newer technologies.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Philips IntelliVue TCG10?

The device is indicated for use in monitoring cardiac and other vital signs in hospital settings, particularly in cardiac care units.

What outcomes have been reported in clinical studies?

Studies report effective detection of cardiac arrhythmias and positive user feedback on the device's interface and usability.

What complications have been reported?

Safety data indicate potential alarm fatigue due to false alarms, but no significant adverse events specific to the device were reported.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.